Fresenius Medical Care AG & Co KGaA ADR buy Societe Generale
Start price
17.11.23
/
50%
€17.70
Target price
17.11.24
-
Performance (%)
15.25%
End price
18.11.24
€20.40
Summary
This prediction ended on 18.11.24 with a price of €20.40. The BUY prediction by Societe_Generale finished with a performance of 15.25%. Dividends of €0.58 are taken into consideration when calculating the performance. Societe_Generale has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Fresenius Medical Care AG & Co KGaA ADR | 0.952% | 0.952% | -3.636% |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% |
Comments by Societe_Generale for this prediction
In the thread Fresenius Medical Care AG & Co KGaA ADR diskutieren
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS) was upgraded by analysts at Societe Generale from a "hold" rating to a "buy" rating.
Ratings data for FMS provided by MarketBeat
In the thread Trading Fresenius Medical Care AG & Co KGaA ADR
Die von Societe_Generale gewählte maximale Laufzeit wurde überschritten